{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:26:09Z","timestamp":1772655969752,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["201579"],"award-info":[{"award-number":["201579"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>High-risk human papillomavirus (HR-HPV) infection is the main cause of cervical cancer, but additional alterations are necessary for its development. Abnormal DNA methylation has an important role in the origin and dissemination of cervical cancer and other human tumors. In this work, we analyzed the methylation of eight genes (AJAP1, CDH1, CDH13, MAGI2, MGMT, MYOD1, RASSF1A and SOX17) that participate in several biological processes for the maintenance of cell normality. We analyzed DNA methylation by methylation-specific PCR (MSP) and HPV infection using the INNO\u2011LiPA genotyping kit in 59 samples diagnostic of normal cervical tissue (non-SIL), 107 low-grade squamous intraepithelial lesions (LSILs), 29 high-grade squamous intraepithelial lesions (HSILs) and 51 cervical cancers (CCs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that all samples of LSIL, HSIL, and CC were HPV-positive, and the genotypes with higher frequencies were 16, 18, 51 and 56. In general, the genes analyzed displayed a significant tendency toward an increase in methylation levels according to increasing cervical lesion severity, except for the CDH13 gene. High CpG island methylator phenotype (CIMP) was associated with a 50.6-fold (95% CI 4.72\u20132267.3)-increased risk of HSIL and a 122-fold risk of CC (95% CI 10.04\u20135349.7).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found that CIMP high was significantly associated with HSIL and CC risk. These results could indicate that CIMP together with HR-HPV infection and other factors participates in the development of HSIL and CC.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13148-021-01224-0","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T13:03:00Z","timestamp":1641474180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Jaqueline","family":"Loaeza-Loaeza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenice","family":"Illades-Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"del Moral-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaneth","family":"Castro-Coronel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Leyva-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Dircio-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Ortiz-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-5553","authenticated-orcid":false,"given":"Daniel","family":"Hern\u00e1ndez-Sotelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"2","key":"1224_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1224_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"3 Suppl 2","key":"1224_CR3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","volume":"110","author":"X Castellsague","year":"2008","unstructured":"Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4-7.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1224_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cdp.2008.09.001","volume":"32","author":"B Illades-Aguiar","year":"2009","unstructured":"Illades-Aguiar B, Cortes-Malagon EM, Antonio-Vejar V, Zamudio-Lopez N, Alarcon-Romero Ldel C, Fernandez-Tilapa G, et al. Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors. Cancer Detect Prev. 2009;32(4):300\u20137.","journal-title":"Cancer Detect Prev"},{"issue":"6","key":"1224_CR5","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1007\/s13277-014-1737-z","volume":"35","author":"J Fang","year":"2014","unstructured":"Fang J, Zhang H, Jin S. Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol. 2014;35(6):5083\u201393.","journal-title":"Tumour Biol"},{"key":"1224_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fgene.2020.00347","volume":"11","author":"H Zhu","year":"2020","unstructured":"Zhu H, Zhu H, Tian M, Wang D, He J, Xu T. DNA methylation and hydroxymethylation in cervical cancer: diagnosis. Prognosis and Treatment Front Genet. 2020;11:347.","journal-title":"Prognosis and Treatment Front Genet"},{"issue":"3","key":"1224_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/carcin\/21.3.461","volume":"21","author":"KD Robertson","year":"2000","unstructured":"Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis. 2000;21(3):461\u20137.","journal-title":"Carcinogenesis"},{"issue":"12","key":"1224_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/15592294.2019.1638701","volume":"14","author":"M Ehrlich","year":"2019","unstructured":"Ehrlich M. DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics. 2019;14(12):1141\u201363.","journal-title":"Epigenetics"},{"key":"1224_CR9","doi-asserted-by":"publisher","first-page":"8260652","DOI":"10.1155\/2018\/8260652","volume":"2018","author":"C Feng","year":"2018","unstructured":"Feng C, Dong J, Chang W, Cui M, Xu T. The progress of methylation regulation in gene expression of cervical cancer. Int J Genomics. 2018;2018:8260652.","journal-title":"Int J Genomics"},{"issue":"1","key":"1224_CR10","first-page":"77","volume":"7","author":"I Peralta-Arrieta","year":"2017","unstructured":"Peralta-Arrieta I, Hernandez-Sotelo D, Castro-Coronel Y, Leyva-Vazquez MA, Illades-Aguiar B. DNMT3B modulates the expression of cancer-related genes and downregulates the expression of the gene VAV3 via methylation. Am J Cancer Res. 2017;7(1):77\u201387.","journal-title":"Am J Cancer Res"},{"issue":"6880","key":"1224_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/416552a","volume":"416","author":"I Rhee","year":"2002","unstructured":"Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416(6880):552\u20136.","journal-title":"Nature"},{"issue":"7","key":"1224_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/15592294.2018.1507197","volume":"13","author":"W Verlaat","year":"2018","unstructured":"Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer C, Van Der Zee AGJ, et al. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer. Epigenetics. 2018;13(7):769\u201378.","journal-title":"Epigenetics"},{"key":"1224_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.mrrev.2017.06.002","volume":"773","author":"MFS Cardoso","year":"2017","unstructured":"Cardoso MFS, Castelletti CHM, Lima-Filho JL, Martins DBG, Teixeira JAC. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles. Mutat Res. 2017;773:161\u201373.","journal-title":"Mutat Res"},{"issue":"9","key":"1224_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijms20092262","volume":"20","author":"M Del Pino","year":"2019","unstructured":"Del Pino M, Sierra A, Marimon L, Marti Delgado C, Rodriguez-Trujillo A, Barnadas E, et al. CADM1, MAL, and miR124 promoter methylation as biomarkers of transforming cervical intrapithelial lesions. Int J Mol Sci. 2019;20(9):10.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1224_CR15","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/jcb.29491","volume":"121","author":"C Li","year":"2020","unstructured":"Li C, Ke J, Liu J, Su J. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer. J Cell Biochem. 2020;121(3):2713\u201324.","journal-title":"J Cell Biochem"},{"issue":"14","key":"1224_CR16","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1158\/1078-0432.CCR-17-3615","volume":"24","author":"W Verlaat","year":"2018","unstructured":"Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, et al. Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples. Clin Cancer Res. 2018;24(14):3456\u201364.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1224_CR17","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1038\/s41598-017-06502-7","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Yao T, Lin Z, Gao Y. Aberrant methylation of MEG3 functions as a potential plasma-based biomarker for cervical cancer. Sci Rep. 2017;7(1):6271.","journal-title":"Sci Rep"},{"issue":"12","key":"1224_CR18","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/cid\/ciz677","volume":"70","author":"K Louvanto","year":"2020","unstructured":"Louvanto K, Aro K, Nedjai B, Butzow R, Jakobsson M, Kalliala I, et al. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia. Clin Infect Dis. 2020;70(12):2582\u201390.","journal-title":"Clin Infect Dis"},{"key":"1224_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-016-0191-8","volume":"8","author":"M Jia","year":"2016","unstructured":"Jia M, Gao X, Zhang Y, Hoffmeister M, Brenner H. Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review. Clin Epigenetics. 2016;8:25.","journal-title":"Clin Epigenetics"},{"issue":"1\u20132","key":"1224_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2014.07.007","volume":"455","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Yamamoto E, Maruyama R, Niinuma T, Kai M. Biological significance of the CpG island methylator phenotype. Biochem Biophys Res Commun. 2014;455(1\u20132):35\u201342.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1224_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ijc.28658","volume":"135","author":"YC Chen","year":"2014","unstructured":"Chen YC, Huang RL, Huang YK, Liao YP, Su PH, Wang HC, et al. Methylomics analysis identifies epigenetically silenced genes and implies an activation of beta-catenin signaling in cervical cancer. Int J Cancer. 2014;135(1):117\u201327.","journal-title":"Int J Cancer"},{"issue":"Pt 1","key":"1224_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2019.08.008","volume":"67","author":"DS Tan","year":"2020","unstructured":"Tan DS, Holzner M, Weng M, Srivastava Y, Jauch R. SOX17 in cellular reprogramming and cancer. Semin Cancer Biol. 2020;67(Pt 1):65\u201373.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1224_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10549-009-0339-8","volume":"119","author":"DY Fu","year":"2010","unstructured":"Fu DY, Wang ZM, Li C, Wang BL, Shen ZZ, Huang W, et al. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat. 2010;119(3):601\u201312.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1224_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41419-018-0782-8","volume":"9","author":"L Li","year":"2018","unstructured":"Li L, Yang WT, Zheng PS, Liu XF. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt\/beta-catenin signaling pathway via trans-suppressing beta-catenin in cervical cancer. Cell Death Dis. 2018;9(7):741.","journal-title":"Cell Death Dis"},{"issue":"17","key":"1224_CR25","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1002\/cam4.3201","volume":"9","author":"JM Moshi","year":"2020","unstructured":"Moshi JM, Hoogduin KJ, Ummelen M, Henfling MER, van Engeland M, Wouters KAD, et al. Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix. Cancer Med. 2020;9(17):6330\u201343.","journal-title":"Cancer Med"},{"issue":"2","key":"1224_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10974-019-09538-6","volume":"40","author":"FC Wardle","year":"2019","unstructured":"Wardle FC. Master control: transcriptional regulation of mammalian Myod. J Muscle Res Cell Motil. 2019;40(2):211\u201326.","journal-title":"J Muscle Res Cell Motil"},{"issue":"4","key":"1224_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ijc.30781","volume":"141","author":"MA Clarke","year":"2017","unstructured":"Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, et al. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer. 2017;141(4):701\u201310.","journal-title":"Int J Cancer"},{"issue":"2","key":"1224_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/ijmr.IJMR_1939_16","volume":"147","author":"S Sood","year":"2018","unstructured":"Sood S, Patel FD, Srinivasan R, Dhaliwal LK. Chemoradiation therapy induces in vivo changes in gene promoter methylation & gene transcript expression in patients with invasive cervical cancer. Indian J Med Res. 2018;147(2):151\u20137.","journal-title":"Indian J Med Res"},{"issue":"10\u201311","key":"1224_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41417-019-0153-3","volume":"27","author":"F Wu","year":"2020","unstructured":"Wu F, Qin Y, Jiang Q, Zhang J, Li F, Li Q, et al. MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells. Cancer Gene Ther. 2020;27(10\u201311):773\u201384.","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"1224_CR30","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1007\/s11033-014-3491-0","volume":"41","author":"R Mahdian","year":"2014","unstructured":"Mahdian R, Nodouzi V, Asgari M, Rezaie M, Alizadeh J, Yousefi B, et al. Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer. Mol Biol Rep. 2014;41(9):6125\u201331.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1224_CR31","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.3802\/jgo.2018.29.e17","volume":"29","author":"CC Chang","year":"2018","unstructured":"Chang CC, Wang HC, Liao YP, Chen YC, Weng YC, Yu MH, et al. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. J Gynecol Oncol. 2018;29(1):e17.","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"1224_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/1940-6207.CAPR-19-0412","volume":"13","author":"BL Valle","year":"2020","unstructured":"Valle BL, Rodriguez-Torres S, Kuhn E, Diaz-Montes T, Parrilla-Castellar E, Lawson FP, et al. HIST1H2BB and MAGI2 methylation and somatic mutations as precision medicine biomarkers for diagnosis and prognosis of high-grade serous ovarian cancer. Cancer Prev Res (Phila). 2020;13(9):783\u201394.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"1224_CR33","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.3892\/ol.2016.5004","volume":"12","author":"V Holubekova","year":"2016","unstructured":"Holubekova V, Mendelova A, Grendar M, Mersakova S, Kapustova I, Jasek K, et al. Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. Oncol Lett. 2016;12(4):2613\u201321.","journal-title":"Oncol Lett"},{"issue":"3","key":"1224_CR34","doi-asserted-by":"publisher","first-page":"e0122495","DOI":"10.1371\/journal.pone.0122495","volume":"10","author":"EM Siegel","year":"2015","unstructured":"Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A, Brown KD. Quantitative DNA methylation analysis of candidate genes in cervical cancer. PLoS ONE. 2015;10(3):e0122495.","journal-title":"PLoS ONE"},{"issue":"5","key":"1224_CR35","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3892\/ijo.2015.3167","volume":"47","author":"H Tanaka","year":"2015","unstructured":"Tanaka H, Kanda M, Koike M, Iwata N, Shimizu D, Ezaka K, et al. Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus. Int J Oncol. 2015;47(5):1811\u20138.","journal-title":"Int J Oncol"},{"issue":"3","key":"1224_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ygyno.2014.10.018","volume":"135","author":"HC Lai","year":"2014","unstructured":"Lai HC, Wang YC, Yu MH, Huang RL, Yuan CC, Chen KJ, et al. DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia. Gynecol Oncol. 2014;135(3):552\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1224_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/1541-7786.MCR-10-0109","volume":"10","author":"N Lin","year":"2012","unstructured":"Lin N, Di C, Bortoff K, Fu J, Truszkowski P, Killela P, et al. Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma. Mol Cancer Res. 2012;10(2):208\u201317.","journal-title":"Mol Cancer Res"},{"issue":"22","key":"1224_CR38","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1158\/1078-0432.CCR-17-1222","volume":"23","author":"A Ooki","year":"2017","unstructured":"Ooki A, Maleki Z, Tsay JJ, Goparaju C, Brait M, Turaga N, et al. A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum DNA. Clin Cancer Res. 2017;23(22):7141\u201352.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1224_CR39","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1038\/s41467-020-17717-0","volume":"11","author":"B Oldrini","year":"2020","unstructured":"Oldrini B, Vaquero-Siguero N, Mu Q, Kroon P, Zhang Y, Galan-Ganga M, et al. MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nat Commun. 2020;11(1):3883.","journal-title":"Nat Commun"},{"issue":"10","key":"1224_CR40","doi-asserted-by":"publisher","first-page":"e0222772","DOI":"10.1371\/journal.pone.0222772","volume":"14","author":"J Huang","year":"2019","unstructured":"Huang J, Luo JY, Tan HZ. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis. PLoS ONE. 2019;14(10):e0222772.","journal-title":"PLoS ONE"},{"issue":"8","key":"1224_CR41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4103\/0366-6999.229896","volume":"131","author":"LL Sun","year":"2018","unstructured":"Sun LL, Liu Y, Sun X, Pan L, Wu D, Wang YD. Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion. Chin Med J (Engl). 2018;131(8):939\u201344.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"1224_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers11070959","volume":"11","author":"G Malpeli","year":"2019","unstructured":"Malpeli G, Innamorati G, Decimo I, Bencivenga M, Nwabo Kamdje AH, Perris R, et al. Methylation dynamics of RASSF1A and its impact on cancer. Cancers (Basel). 2019;11(7):10.","journal-title":"Cancers (Basel)"},{"issue":"1\u20132","key":"1224_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1155\/2007\/291538","volume":"23","author":"LB Hesson","year":"2007","unstructured":"Hesson LB, Cooper WN, Latif F. The role of RASSF1A methylation in cancer. Dis Markers. 2007;23(1\u20132):73\u201387.","journal-title":"Dis Markers"},{"key":"1224_CR44","first-page":"10","volume":"21","author":"D Raos","year":"2021","unstructured":"Raos D, Ulamec M, Katusic Bojanac A, Bulic-Jakus F, Jezek D, Sincic N. Epigenetically inactivated RASSF1A as a tumor biomarker. Bosn J Basic Med Sci. 2020;21:10.","journal-title":"Bosn J Basic Med Sci"},{"issue":"9","key":"1224_CR45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.20787","volume":"49","author":"AV Andreeva","year":"2010","unstructured":"Andreeva AV, Kutuzov MA. Cadherin 13 in cancer. Genes Chromosomes Cancer. 2010;49(9):775\u201390.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"1224_CR46","first-page":"5715","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhang L, Yang J, Li B, Wang J. CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells. Oncol Lett. 2018;16(5):5715\u201322.","journal-title":"Oncol Lett"},{"issue":"8","key":"1224_CR47","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.7150\/jca.37762","volume":"11","author":"D Xu","year":"2020","unstructured":"Xu D, Yuan H, Meng Z, Yang C, Li Z, Li M, et al. Cadherin 13 inhibits pancreatic cancer progression and epithelial-mesenchymal transition by Wnt\/beta-Catenin signaling. J Cancer. 2020;11(8):2101\u201312.","journal-title":"J Cancer"},{"issue":"4","key":"1224_CR48","doi-asserted-by":"publisher","first-page":"e5956","DOI":"10.1097\/MD.0000000000005956","volume":"96","author":"M Ye","year":"2017","unstructured":"Ye M, Huang T, Li J, Zhou C, Yang P, Ni C, et al. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines. Medicine (Baltimore). 2017;96(4):e5956.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1224_CR49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21641\/los.15.1.58","volume":"15","author":"P Sen","year":"2018","unstructured":"Sen P, Ganguly P, Ganguly N. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer. Oncol Lett. 2018;15(1):11\u201322.","journal-title":"Oncol Lett"},{"issue":"6","key":"1224_CR50","doi-asserted-by":"publisher","first-page":"948","DOI":"10.33594\/000000188","volume":"53","author":"EG Salmeron-Barcenas","year":"2019","unstructured":"Salmeron-Barcenas EG, Illades-Aguiar B, Del Moral-Hernandez O, Ortega-Soto A, Hernandez-Sotelo D. HOTAIR knockdown decreased the activity Wnt\/beta-catenin signaling pathway and increased the mRNA levels of its negative regulators in hela cells. Cell Physiol Biochem. 2019;53(6):948\u201360.","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"1224_CR51","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.7150\/jca.22005","volume":"9","author":"M Yang","year":"2018","unstructured":"Yang M, Wang M, Li X, Xie Y, Xia X, Tian J, et al. Wnt signaling in cervical cancer? J Cancer. 2018;9(7):1277\u201386.","journal-title":"J Cancer"},{"issue":"12","key":"1224_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms21124272","volume":"21","author":"A McMellen","year":"2020","unstructured":"McMellen A, Woodruff ER, Corr BR, Bitler BG, Moroney MR. Wnt signaling in gynecologic malignancies. Int J Mol Sci. 2020;21(12):10.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1224_CR53","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/jcb.25992","volume":"118","author":"A Bahrami","year":"2017","unstructured":"Bahrami A, Hasanzadeh M, ShahidSales S, Yousefi Z, Kadkhodayan S, Farazestanian M, et al. Clinical significance and prognosis value of Wnt signaling pathway in cervical cancer. J Cell Biochem. 2017;118(10):3028\u201333.","journal-title":"J Cell Biochem"},{"issue":"4","key":"1224_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng1990","volume":"39","author":"M Weber","year":"2007","unstructured":"Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007;39(4):457\u201366.","journal-title":"Nat Genet"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-021-01224-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-021-01224-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-021-01224-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T20:27:48Z","timestamp":1726432068000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-021-01224-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1186\/s13148-021-01224-0","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Bioethics and Research Committee of the Universidad Aut\u00f3noma de Guerrero approved the study, which was performed in accordance with the recommendations of the Declaration of Helsinki (2013) for biomedical research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}